Effects of omeprazole and famotidine on fibroblast growth factor-2 during artificial gastric ulcer healing in humans

Motohiro Esaki, Kunihiko Aoyagi, Takayuki Matsumoto, Yasuyuki Kuwano, Michio Shimizu, Masatoshi Fujishima

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background and aims. Endoscopic mucosal resection is a widely accepted technique for the treatment of early gastric cancers, while large ulcers induced by the treatment should be treated promptly. This study aimed to compare the effects of omeprazole and famotidine on ulcer healing and fibroblast growth factor-2 levels in gastric ulcers induced by endoscopic mucosal resection. Methods. Sixteen patients indicated for endoscopic mucosal resection were enrolled. They were treated by using either omeprazole (n = 8) or famotidine (n = 8) after endoscopic mucosal resection. Endoscopy was performed on days 4, 7 and 28 during each treatment period. Levels of fibroblast growth factor-2 in biopsy specimens were measured by using an enzyme-linked immunosorbent assay at the time of and after endoscopic mucosal resection. Histological variables were also assessed. Results. Ulcer healing rates under endoscopy were not different between the two treatment groups. In both groups, levels of fibroblast growth factor-2 slightly increased on day 4, but the values were not different at any time point. There were no differences in histological variables on days 4 and 7, but fibromuscular hyperplasia was significantly greater in the omeprazole group than in the famotidine group on day 28 (P<0.05). Conclusions. Omeprazole and famotidine have an equivalent value for the treatment of ulcers induced by endoscopic mucosal resection. While omeprazole had a more potent effect on fibromuscular hyperplasia than did famotidine, such a difference does not seem to be explained by fibroblast growth factor-2.

Original languageEnglish
Pages (from-to)365-369
Number of pages5
JournalEuropean Journal of Gastroenterology and Hepatology
Volume14
Issue number4
DOIs
Publication statusPublished - May 6 2002

Fingerprint

Famotidine
Omeprazole
Fibroblast Growth Factor 2
Stomach Ulcer
Ulcer
Endoscopy
Hyperplasia
Therapeutics
Stomach Neoplasms
Endoscopic Mucosal Resection
Enzyme-Linked Immunosorbent Assay
Biopsy

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology

Cite this

Effects of omeprazole and famotidine on fibroblast growth factor-2 during artificial gastric ulcer healing in humans. / Esaki, Motohiro; Aoyagi, Kunihiko; Matsumoto, Takayuki; Kuwano, Yasuyuki; Shimizu, Michio; Fujishima, Masatoshi.

In: European Journal of Gastroenterology and Hepatology, Vol. 14, No. 4, 06.05.2002, p. 365-369.

Research output: Contribution to journalArticle

Esaki, Motohiro ; Aoyagi, Kunihiko ; Matsumoto, Takayuki ; Kuwano, Yasuyuki ; Shimizu, Michio ; Fujishima, Masatoshi. / Effects of omeprazole and famotidine on fibroblast growth factor-2 during artificial gastric ulcer healing in humans. In: European Journal of Gastroenterology and Hepatology. 2002 ; Vol. 14, No. 4. pp. 365-369.
@article{e20b0e76dd584e98809e6aa900b0541f,
title = "Effects of omeprazole and famotidine on fibroblast growth factor-2 during artificial gastric ulcer healing in humans",
abstract = "Background and aims. Endoscopic mucosal resection is a widely accepted technique for the treatment of early gastric cancers, while large ulcers induced by the treatment should be treated promptly. This study aimed to compare the effects of omeprazole and famotidine on ulcer healing and fibroblast growth factor-2 levels in gastric ulcers induced by endoscopic mucosal resection. Methods. Sixteen patients indicated for endoscopic mucosal resection were enrolled. They were treated by using either omeprazole (n = 8) or famotidine (n = 8) after endoscopic mucosal resection. Endoscopy was performed on days 4, 7 and 28 during each treatment period. Levels of fibroblast growth factor-2 in biopsy specimens were measured by using an enzyme-linked immunosorbent assay at the time of and after endoscopic mucosal resection. Histological variables were also assessed. Results. Ulcer healing rates under endoscopy were not different between the two treatment groups. In both groups, levels of fibroblast growth factor-2 slightly increased on day 4, but the values were not different at any time point. There were no differences in histological variables on days 4 and 7, but fibromuscular hyperplasia was significantly greater in the omeprazole group than in the famotidine group on day 28 (P<0.05). Conclusions. Omeprazole and famotidine have an equivalent value for the treatment of ulcers induced by endoscopic mucosal resection. While omeprazole had a more potent effect on fibromuscular hyperplasia than did famotidine, such a difference does not seem to be explained by fibroblast growth factor-2.",
author = "Motohiro Esaki and Kunihiko Aoyagi and Takayuki Matsumoto and Yasuyuki Kuwano and Michio Shimizu and Masatoshi Fujishima",
year = "2002",
month = "5",
day = "6",
doi = "10.1097/00042737-200204000-00005",
language = "English",
volume = "14",
pages = "365--369",
journal = "European Journal of Gastroenterology and Hepatology",
issn = "0954-691X",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Effects of omeprazole and famotidine on fibroblast growth factor-2 during artificial gastric ulcer healing in humans

AU - Esaki, Motohiro

AU - Aoyagi, Kunihiko

AU - Matsumoto, Takayuki

AU - Kuwano, Yasuyuki

AU - Shimizu, Michio

AU - Fujishima, Masatoshi

PY - 2002/5/6

Y1 - 2002/5/6

N2 - Background and aims. Endoscopic mucosal resection is a widely accepted technique for the treatment of early gastric cancers, while large ulcers induced by the treatment should be treated promptly. This study aimed to compare the effects of omeprazole and famotidine on ulcer healing and fibroblast growth factor-2 levels in gastric ulcers induced by endoscopic mucosal resection. Methods. Sixteen patients indicated for endoscopic mucosal resection were enrolled. They were treated by using either omeprazole (n = 8) or famotidine (n = 8) after endoscopic mucosal resection. Endoscopy was performed on days 4, 7 and 28 during each treatment period. Levels of fibroblast growth factor-2 in biopsy specimens were measured by using an enzyme-linked immunosorbent assay at the time of and after endoscopic mucosal resection. Histological variables were also assessed. Results. Ulcer healing rates under endoscopy were not different between the two treatment groups. In both groups, levels of fibroblast growth factor-2 slightly increased on day 4, but the values were not different at any time point. There were no differences in histological variables on days 4 and 7, but fibromuscular hyperplasia was significantly greater in the omeprazole group than in the famotidine group on day 28 (P<0.05). Conclusions. Omeprazole and famotidine have an equivalent value for the treatment of ulcers induced by endoscopic mucosal resection. While omeprazole had a more potent effect on fibromuscular hyperplasia than did famotidine, such a difference does not seem to be explained by fibroblast growth factor-2.

AB - Background and aims. Endoscopic mucosal resection is a widely accepted technique for the treatment of early gastric cancers, while large ulcers induced by the treatment should be treated promptly. This study aimed to compare the effects of omeprazole and famotidine on ulcer healing and fibroblast growth factor-2 levels in gastric ulcers induced by endoscopic mucosal resection. Methods. Sixteen patients indicated for endoscopic mucosal resection were enrolled. They were treated by using either omeprazole (n = 8) or famotidine (n = 8) after endoscopic mucosal resection. Endoscopy was performed on days 4, 7 and 28 during each treatment period. Levels of fibroblast growth factor-2 in biopsy specimens were measured by using an enzyme-linked immunosorbent assay at the time of and after endoscopic mucosal resection. Histological variables were also assessed. Results. Ulcer healing rates under endoscopy were not different between the two treatment groups. In both groups, levels of fibroblast growth factor-2 slightly increased on day 4, but the values were not different at any time point. There were no differences in histological variables on days 4 and 7, but fibromuscular hyperplasia was significantly greater in the omeprazole group than in the famotidine group on day 28 (P<0.05). Conclusions. Omeprazole and famotidine have an equivalent value for the treatment of ulcers induced by endoscopic mucosal resection. While omeprazole had a more potent effect on fibromuscular hyperplasia than did famotidine, such a difference does not seem to be explained by fibroblast growth factor-2.

UR - http://www.scopus.com/inward/record.url?scp=0036232184&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036232184&partnerID=8YFLogxK

U2 - 10.1097/00042737-200204000-00005

DO - 10.1097/00042737-200204000-00005

M3 - Article

C2 - 11943947

AN - SCOPUS:0036232184

VL - 14

SP - 365

EP - 369

JO - European Journal of Gastroenterology and Hepatology

JF - European Journal of Gastroenterology and Hepatology

SN - 0954-691X

IS - 4

ER -